An experienced transportation executive, Robert Rogulic serves as president and CEO of Tri-National Inc., a trucking company that he founded. Through his company, Robert Rogulic offers extensive support to the Kilo Foundation, an organization that funds diabetes research. Each year, Tri-National donates in excess of $10,000 to the Kilo Foundation.
Part of the funding that the foundation provides for research goes to the Washington University School of Medicine’s Division of Endocrinology, Diabetes, and Metabolism. This money fuels research on potential diabetes therapies. Currently, two studies are looking at different techniques for causing the generation of insulin-producing cells. One team has devised a way of forcing cells in the pancreas that do not normally produce insulin to generate enough to regulate blood sugar. Another team is working on “tricking” skin cells and other common cells into producing insulin.
Researchers at the Washington University School of Medicine are also working on better diabetes medical devices, such as insulin pumps that automatically suspend insulin delivery when blood sugar becomes too low. These pumps continually monitor glucose and could become tools for teaching individuals with diabetes how to optimize diet and exercise.